Literature DB >> 28948962

Eschar is associated with poor prognosis in scrub typhus.

Vivek Chauhan1, Anurag Thakur1, Suman Thakur2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28948962      PMCID: PMC5644306          DOI: 10.4103/ijmr.IJMR_1888_15

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Sir, Scrub typhus occurs in almost all parts of India and is endemic1. Many researchers have reported the profile of scrub typhus from various parts of India with diagnosis based on IgM ELISA234. Eschar is pathognomonic for rickettsiosis including scrub typhus, but its presence has not been reported as a marker of disease severity. Kim et al5 found absence of eschar to have prognostic significance in their study. We report here results of a retrospective analysis of IgM positive adult patients with scrub typhus showing eschar as a marker of severe rickettsiosis. This retrospective, hospital record-based observational study was conducted in Dr Rajendra Prasad Government Medical College, Kangra, Tanda, Himachal Pradesh, India. The files of all fever patients from the record section who were admitted between January and December 2015, were reviewed. Those patients who had a diagnosis of scrub typhus based on confirmed IgM-positive ELISA test were included. The IgM kits used for testing were obtained from InBios International, Seattle, WA, USA. Those with co-infections such as malaria, leptospirosis, typhoid, tuberculosis and hepatitis, patients diagnosed as scrub typhus but IgM −ve and those diagnosed as scrub typhus on clinical suspicion where IgM ELISA was not done, were excluded. The data were extracted from the files and analyzed using SPSS software (version 23, SPSS, Inc., Chicago, IL, USA). The patients were labelled as having sepsis, severe sepsis, septic shock and multi-organ dysfunction syndrome according to the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee6. Patients were divided into two groups: eschar +ve and eschar −ve for analysis. Distribution of continuous variables in two groups, eschar +ve and eschar −ve, was compared using unpaired t test and Fisher's exact for categorical variables. Multivariate logistic regression was used to model the strength of association of other biologically plausible variables such as age and gender in addition to eschar on each of the outcome variables that were found to have significantly high distribution in patients with eschar. A total of 74 records of fever with a diagnosis of scrub typhus were obtained, but only 61 patients had a documented IgM ELISA-positivity for scrub typhus. Since, no test was done to rule out leptospirosis in the first week of illness, all patients were given doxycycline (100 mg b.i.d) for 5-7 days and ceftriaxone injection (1g b.i.d) for 7-10 days to cover for both scrub typhus and leptospirosis. Scrub typhus was confirmed in these patients using IgM ELISA. No patient was found with co-infection of scrub typhus and leptospirosis. Malaria was ruled out in all patients using malaria rapid antigen card test. Totally, 61 IgM+ scrub typhus patients were included, of whom 42 (69%) were females. Age range was 18-69 yr, with a mean of 41.19±13 yr. Mean hospital stay was 5.1±0.57 days. Mean fever duration before admission was 6.1 days, and mean temperature was 39.31°C. The distribution of clinical and biochemical variables in scrub typhus patients is shown in Table I. Among the symptoms, myalgia 49 (80%), pain abdomen 30 (49%), shortness of breath 28 (46%) and headache 27 (44%) were common. Jaundice 17 (28%), meningoencephalitis 6 (10%), rash 2 (3%), pleural effusion 1 (1.5%) and ascites 1 (1.5%) were other less common complaints.
Table I

Distribution of variables (clinical and biochemical) in scrub typhus patients (n=61)

Distribution of variables (clinical and biochemical) in scrub typhus patients (n=61) Sepsis was established in 56 (92%), of whom 52 (85%) had severe sepsis. Mean blood pressure <70 mm Hg was present in 26 (42%) patients, and septic shock needing vasopressors was present in 15 (25%). Steroids were given to eight (13%), and supplemental oxygen was given to 22 (36%). Multi-organ dysfunction syndrome was diagnosed in 28 (46%). Ultrasound was suggestive of cholecystitis in 27 (44.26%) and that of hepatomegaly in 26 (43%). Eschar +ve 22 (36%) patients were compared with eschar −ve 39 (64%) patients to see if the distribution of clinical, biochemical and outcome variables was different in these two groups (Table II). The baseline characteristics such as age and gender were comparable. Mean age in eschar +ve group was 42.5±14 yr, while it was 40.4±12 yr in the eschar −ve group. Multivariate logistic regression was used to model the strength of association of age, gender and eschar on each of the parameters that showed significantly high distribution in eschar +ve patients. Keeping age and gender constant, eschar was found to have significant independent association with respiratory rate >24/min, mean blood pressure <70 mmHg, oliguria or serum urea >60 mg/dl, serum creatinine >1.1 mg/dl, oxygen saturation <90 per cent, platelet count <80,000/μl, bilirubin >2 mg/dl (or AST/ALT) >150 U/l, need for inotrope support, need for oxygen support, need for intravenous fluids, steroid use, pain abdomen, myalgia, findings of cholecystitis on ultrasound and duration of hospital stay (Table II).
Table II

Strength of association of eschar with various clinical and biochemical parameters

Strength of association of eschar with various clinical and biochemical parameters Eschar is a common finding in scrub typhus and spotted fever group rickettsiosis, but its positive association with disease severity has not been established in clinical studies. Sonthayanon et al7 from Thailand found presence of an eschar associated with higher bacterial load in blood, and they speculated that there might be a possible link between the development of an eschar and the size of initial inoculum or the virulence of the infecting strain. This study used molecular techniques for diagnosis and the association of eschar with high viral loads was a significant finding. We could not find any study showing positive association of eschar with the severity in disease in scrub typhus patients. Kim et al5, however, showed the absence of eschar to be associated with severity, which was contrary to our observations. Sriwongpan et al8 found almost equal (56±4%) distribution of eschar in non-severe, severe and deceased scrub typhus patients. On multivariate logistic regression using variables such as age, gender and eschar as predictors, significant independent association of eschar was found with the respiratory rate >24/min, mean blood pressure <70 mmHg, oliguria or serum urea >60 mg/dl, serum creatinine >1.1 mg/dl, oxygen saturation <90 per cent, platelet count <80,000/μl, bilirubin >2 mg/dl (or AST/ALT >150 U/l), need for inotrope support, need for oxygen support, need for intravenous fluids, pain abdomen, findings of cholecystitis on ultrasound and duration of hospital stay (Table III).
Table III

Multivariate logistic regression showing the strength of association of eschar with the variables

Multivariate logistic regression showing the strength of association of eschar with the variables Eschar is produced as a part of immune response to the rickettsial antigens in the body and biopsy of the eschar shows leukocytoclastic vasculitis7. Hyperactive immune response behind eschar formation may also be responsible for renal, respiratory, haematological and circulatory organ involvement and severe illness in eschar +ve scrub typhus patients. Other plausible explanations include high inoculum load in patients with eschar leading to higher DNA loads and thus eschar and severe disease7. It may also be explained on the basis of virulence of the prevalent strains that causes eschar formation, higher DNA loads and severity of disease. Our study had some limitations. The study was done in a tertiary care setting, so the results cannot be extrapolated to the scrub typhus patients in community. Arterial blood gas analysis (pO2) was not done, so specific diagnosis of acute respiratory distress syndrome could not be made in the patients. To conclude, the presence of eschar in IgM+ scrub typhus patients was found to be associated with symptom severity including renal, haematological, respiratory and circulatory systems, longer hospital stay and higher mortality in this group compared to eschar −ve IgM+ scrub typhus patients. Further studies need to be done to determine the causes behind this association.
  8 in total

1.  Scrub Typhus Seroprevalence in Healthy Indian Population.

Authors:  Mallika Sengupta; Shalini Anandan; Dolly Daniel; John Antony Jude Prakash
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 2.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

3.  Diagnostic validation of selected serological tests for detecting scrub typhus.

Authors:  Munegowda Koraluru; Indira Bairy; Muralidhar Varma; Sudha Vidyasagar
Journal:  Microbiol Immunol       Date:  2015-07       Impact factor: 1.955

4.  Clinical and laboratory findings associated with severe scrub typhus.

Authors:  Dong-Min Kim; Seok Won Kim; Seong-Hyung Choi; Na Ra Yun
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

5.  Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus.

Authors:  Piengchan Sonthayanon; Wirongrong Chierakul; Vanaporn Wuthiekanun; Kriangsak Phimda; Sasithon Pukrittayakamee; Nicholas P Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

Review 6.  Severe scrub typhus infection: Clinical features, diagnostic challenges and management.

Authors:  John Victor Peter; Thomas I Sudarsan; John Anthony J Prakash; George M Varghese
Journal:  World J Crit Care Med       Date:  2015-08-04

7.  DHR-ICMR Guidelines for diagnosis & management of Rickettsial diseases in India.

Authors:  Manuj Rahi; M D Gupte; Anurag Bhargava; George M Varghese; Rashmi Arora
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

8.  Clinical indicators for severe prognosis of scrub typhus.

Authors:  Pamornsri Sriwongpan; Pornsuda Krittigamas; Pacharee Kantipong; Naowarat Kunyanone; Jayanton Patumanond; Sirianong Namwongprom
Journal:  Risk Manag Healthc Policy       Date:  2013-10-11
  8 in total
  3 in total

1.  Scrub typhus in a primary health care center of Nepal: A case series.

Authors:  Shekhar Gurung; Saurab Karki; Subashchandra Pokharel; Kishor Bhatta
Journal:  Ann Med Surg (Lond)       Date:  2022-03-08

2.  Validation of a Clinical Risk-scoring Algorithm for Scrub Typhus Severity in South India.

Authors:  Shivali Gulati; Kiran Chunduru; Mridula Madiyal; Maninder S Setia; Kavitha Saravu
Journal:  Indian J Crit Care Med       Date:  2021-05

3.  Dual Genotype Orientia tsutsugamushi Infection in Patient with Rash and Eschar, Vietnam, 2016.

Authors:  Nhiem Le-Viet; Duc-Tuan Phan; Nho Le-Viet; Sinh Trinh; Muoi To; Didier Raoult; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.